Chronic Matrix Metalloproteinase Inhibition Following Myocardial Infarction in Mice: Differential Effects on Short and Long-Term Survival
Authors:
- Francis G. SpinaleFSFrancis G. Spinale
- G. Patricia EscobarGEG. Patricia Escobar
- Jennifer W. HendrickJHJennifer W. Hendrick
- Leslie L. ClarkLCLeslie L. Clark
- Sarah S. CamensSCSarah S. Camens
- Joseph P. MingoiaJMJoseph P. Mingoia
- Christina G. SquiresCSChristina G. Squires
- Robert E. StroudRSRobert E. Stroud
- John S. IkonomidisJIJohn S. Ikonomidis
- 1 September 2006
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 318 (3) , 966-973
Abstract
Left ventricular (LV) remodeling occurs after myocardial infarction (MI), and the matrix metalloproteinases (MMPs) contribute to adverse LV remodeling after MI. Short-term pharmacological MMP inhibition (MMPi; days to weeks) in animal models of MI have demonstrated a reduction in adverse LV remodeling. However, the long-term effects (months) of MMPi on survival and LV remodeling after MI have not been examined. MI was induced in adult mice (n = 131) and, at 3 days post-MI, assigned to MMPi [MI-MMPi: (s)-2-(4-bromo-biphenyl-4-sulfonylamino)-3-methyl-butyric acid (PD200126), 7.5 mg/day/p.o., n = 64] or untreated (MI-only, n = 67). Unoperated mice (n = 16) served as controls. The median survival in the MI-only group was 5 days, whereas median survival was significantly greater in the MI-MMPi group at 38 days (p < 0.05). However, with prolonged MMPi (>120 days), a significant divergence in the survival curves occurred in which significantly greater mortality was observed with prolonged MMPi (p < 0.05). LV echocardiography at 6 months revealed LV dilation in the MI-only and MI-MMPi groups (154 ± 14 and 219 ± 24 μl) compared with control (67 ± 4 μl, p < 0.05), with a greater degree of dilation in the MI-MMPi group (p < 0.05). MMPi conferred a beneficial effect on survival early post-MI, but prolonged MMPi (>3 months) was associated with higher mortality and adverse LV remodeling. These unique results suggest that an optimal temporal window exists with respect to pharmacological interruption of MMP activity in the post-MI period.Keywords
This publication has 39 references indexed in Scilit:
- Gender differences in cardiac function during early remodeling after acute myocardial infarction in miceLife Sciences, 2004
- Inflammatory Cytokines and Postmyocardial Infarction RemodelingCirculation Research, 2004
- Matrix metalloproteinases, oxidative stress and the acute response to acute myocardial ischaemia and reperfusionCurrent Opinion in Pharmacology, 2004
- Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administrationInternational Journal of Cardiology, 2004
- Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathyJACC, 2002
- Matrix Metalloproteinases and Their Role in Pancreatic Cancer: A Review of Preclinical Studies and Clinical TrialsAnnals of Surgical Oncology, 2002
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and TribulationsScience, 2002
- Matrix metalloproteinases: a tail of a frog that became a princeNature Reviews Molecular Cell Biology, 2002
- Disruption of the Plasminogen Gene in Mice Abolishes Wound Healing after Myocardial InfarctionThe American Journal of Pathology, 2000
- Cellular reactions against Burkitt lymphoma cells. III. Effector cell activity of leukocytes stimulated in vitro with autochthonous cultured lymphoma cellsInternational Journal of Cancer, 1972